Cargando…
The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia
BACKGROUND: Atypical antipsychotics provide better control of the negative and affective symptoms of schizophrenia when compared with conventional neuroleptics; nevertheless, their heightened ability to improve cognitive dysfunction remains a matter of debate. This study aimed to examine the changes...
Autores principales: | Selva-Vera, Gabriel, Balanzá-Martínez, Vicent, Salazar-Fraile, José, Sánchez-Moreno, José, Martinez-Aran, Anabel, Correa, Patricia, Vieta, Eduard, Tabarés-Seisdedos, Rafael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898740/ https://www.ncbi.nlm.nih.gov/pubmed/20550658 http://dx.doi.org/10.1186/1471-244X-10-47 |
Ejemplares similares
-
Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients
por: Torrent, Carla, et al.
Publicado: (2010) -
MICEmi: A method to identify cognitive endophenotypes of mental illnesses
por: Correa-Ghisays, Patricia, et al.
Publicado: (2022) -
Staging, Neurocognition and Social Functioning in Bipolar Disorder
por: Tatay-Manteiga, Amparo, et al.
Publicado: (2018) -
Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study
por: Garés-Caballer, Marta, et al.
Publicado: (2022) -
Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates
por: Balanzá-Martínez, Vicent, et al.
Publicado: (2015)